GMAB GENMAB A/S
Price Chart
Executive Summary
Genmab A/S filed a 6-K reporting a routine grant of 15,894 restricted stock units and 15,494 warrants to employees. The grants are standard long-term incentive compensation with 3-year vesting, representing a minimal and immaterial dilution relative to the company's $15.7B market cap.
Actionable Insight
No trade signal. This is a standard employee compensation grant with no immediate financial or strategic implications. Monitor next quarterly filing for any changes in outstanding share count from ongoing equity programs.
Key Facts
- Grant of 15,894 restricted stock units and 15,494 warrants to employees on June 11, 2026.
- RSU fair value of DKK 1,616.50 per unit (closing price on grant date); warrant fair value of DKK 534.23 per warrant (Black-Scholes).
- Both instruments vest three years from grant date; warrants expire at the seventh anniversary.
- The awards are cost-free to recipients; exercise price per warrant is DKK 1,616.50.
- Total potential dilution is negligible relative to Genmab's outstanding share count (~$15.7B market cap).
Financial Impact
Immaterial — combined fair value of roughly DKK 33.9M (~$4.8M) based on RSU fair value of ~DKK 25.7M and warrant fair value of ~DKK 8.3M; this is less than 0.03% of market cap.
Risk Factors
- None from this filing; equity compensation programs are routine for a biotech company.
Market Snapshot
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001434265-26-000087 |
| Document: gmab_20260611xx6k.htm | 0001434265-26-000087 |
| Document: 0001434265-26-000087-index-headers.html | 0001434265-26-000087 |
| Document: 0001434265-26-000087-index.html | 0001434265-26-000087 |
| Document: 0001434265-26-000087.txt | 0001434265-26-000087 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 11, 2026
3d ago
|
6-K
| $25.21 awaiting T+60 | awaiting T+60 | — | $25.08 (−0.52%) |
|
Jun 11, 2026
3d ago
|
Institutional Cluster
| $24.48 awaiting T+60 | awaiting T+60 | — | $25.08 (−2.45%) |
|
Feb 28, 2026
15w ago
|
Institutional Cluster
| $29.65 $26.89 | ▼ −9.31% | ▼ −18.64% | $25.08 (−15.41%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access